MIRISK
LIVE

Serial Number

97315103

Owner

Hummingbird Diagnostics GmbH

Attorney

MARGARET C. MCHUGH

Filing Date

Mar 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MIRISK Trademark

Serial Number: 97315103

MIRISK is a trademark filed by Hummingbird Diagnostics GmbH on March 16, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Hummingbird Diagnostics GmbH (7 trademarks)

Im Neuenheimer Feld 583
Heidelberg 69120 , DE

Entity Type: 16

Trademark Details

Filing Date

March 16, 2022

Registration Date

Not Registered

Published for Opposition

January 27, 2026

Goods & Services

Chemicals for use in industry and science; reagents for use in industry and science; test and collection kits containing chemicals for use in industry and science; sampling kits containing chemicals for use in industry and science; diagnostic kits containing chemicals for use in industry and science

Diagnostic preparations for medical use; diagnostic preparations for medical use and pharmaceutical research use; diagnostic preparations for medical purposes; sampling kits containing preparations for medical or pharmaceutical purposes use, namely, chemical reagents for sampling bodily fluids and tissue; test kits consisting of chemical reagents for medical purposes; kits consisting of chemical reagents for medical purposes

Scientific and technological services, namely, scientific research, analysis, and testing in the field of disease diagnosis; scientific analysis and research services in the medical, biotechnological and equipment diagnostic fields; industrial analysis and research services in the medical, biotechnological and equipment diagnostic fields; research and related development of pharmaceutical products and substances; development of new medicines; scientific research services for diagnostic purposes; scientific research, namely, preparing scientific opinions; scientific research consulting; contract research in the field of pharmacological and clinical development of medicinal products; medical research services, namely, analysis of data and clinical trials

Medical and veterinary services; health care for humans and animals; medical and veterinary diagnostic testing, monitoring and reporting services in pre-clinical and clinical areas; medical and veterinary diagnostic testing, monitoring and reporting services for humans and animals; services of a medical diagnostic laboratory, namely, analysis, detection and identification of components in bodily samples and tissue; medical analysis services relating to the treatment of humans and animals; medical diagnostic services for determining diseases or disorders, monitoring diseases or disorders, and determining the therapeutic success of diseases or disorders; non-invasive medical diagnostic testing, monitoring and reporting services; blood and biopsy-based medical diagnostic testing, monitoring and reporting services; personalized medical diagnostic testing, monitoring and reporting services; medical services, namely, diagnostic health monitoring and health surveillance

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 27, 2026 ETOP
OPPOSITION INSTITUTED NO. 999999
May 27, 2026 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 11, 2026 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 27, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 27, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 21, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 18, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 18, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 18, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 18, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 12, 2025 GNFN
FINAL REFUSAL E-MAILED
Dec 12, 2025 GNFR
FINAL REFUSAL WRITTEN
Dec 12, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2024 CRFA
ASSIGNED TO LIE
May 30, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 27, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 7, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 7, 2023 GNSL
SUSPENSION LETTER WRITTEN
Dec 7, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 2, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 25, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 23, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2022 NWOS
NEW APPLICATION ENTERED
Mar 19, 2022 NWAP